Skip to main content

Adial Pharmaceuticals, Inc. (ADIL)

NASDAQ: ADIL · IEX Real-Time Price · USD
3.34 -0.14 (-4.02%)
Oct 25, 2021 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year20202019201820172016
Selling, General & Admin
5.074.286.620.810.26
Research & Development
5.853.970.370.180.15
Operating Expenses
10.938.246.9910.41
Operating Income
-10.93-8.24-6.99-1-0.41
Interest Expense / Income
001.170.140.01
Other Expense / Income
-0.030.353.48-0-0
Pretax Income
-10.89-8.59-11.63-1.14-0.42
Net Income
-10.89-8.59-11.63-1.14-0.42
Net Income Common
-10.89-8.59-11.63-1.14-0.42
Shares Outstanding (Basic)
1210533
Shares Outstanding (Diluted)
1210533
Shares Change
26.50%107.01%45.80%0.20%-
EPS (Basic)
-0.87-0.87-2.44-0.35-0.13
EPS (Diluted)
-0.87-0.87-2.44-0.35-0.13
Free Cash Flow Per Share
-0.61-0.64-0.53-0.15-0.08
EBITDA
-10.89-8.59-10.46-0.99-0.41
EBIT
-10.89-8.59-10.46-0.99-0.41
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).